Selskabets formål er fremstilling af farmaceutiske præparater, forskning og eksperimentel udvikling indenfor bioteknologi.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | -23.4 mio. | -33.8 mio. | 38.8 mio. | 37.9 mio. | 17 | |
CVR: 42642649
Compared to 994 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Thomas Lars Andresen joined the board
Mikkel Wandahl Pedersen left the board
Thomas Lars Andresen joined as ADM. DIR.
Mikkel Wandahl Pedersen left as ADM. DIR.
Novo Holdings A/S registered with 25% ownership
Commit Biologics Holding ApS registered with 15% ownership
registered with 25% ownership
registered with 15% ownership
Mikkel Wandahl Pedersen joined the board
Companies in the same industry and area
companydata.dk